Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

NCT05947136 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT05947136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05947136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Recruiting
Start date
January 19, 2024
Completion date
September 14, 2029
Enrollment
204 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

complication, multiple myeloma